goralatide has been researched along with Pulmonary Fibrosis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, F; Li, T; Li, Y; Liu, H; Mao, N; Sun, Y; Xu, H; Yang, F; Yang, H; Yang, X; Yin, J | 1 |
| Deng, HJ; Gong, HB; Gong, RB; Miao, ZY; Tang, XY; Zhang, CM | 1 |
| Gao, X; Geng, Y; Li, H; Lin, G; Mao, N; Qian, Y; Wang, J; Xu, H; Yang, F; Zhang, G | 1 |
| Gao, X; Geng, Y; Li, Q; Li, S; Liu, Y; Wang, R; Wei, Z; Xu, D; Xu, H; Yang, F; Yang, Y; Zhang, L; Zhang, W | 1 |
| Gao, X; Li, S; Wang, R; Wei, Z; Xu, D; Xu, H; Yang, F; Yi, X; Zhang, B; Zhang, G; Zhang, H; Zhang, L; Zhang, X; Zhang, Y; Zhu, Y | 1 |
| Cai, W; Gao, X; Hao, X; Jin, F; Li, D; Li, S; Liu, H; Liu, Y; Mao, N; Tao, T; Wei, Z; Xu, D; Xu, H; Yang, F; Zhang, B; Zhang, G; Zhang, H; Zhang, L | 1 |
| Feng, HL; Li, ZG; Ma, WD; Wang, RM; Wei, ZQ; Xu, H; Yang, F; Yu, WY | 1 |
| Conte, E; Cuzzocrea, S; Esposito, E; Fagone, E; Fruciano, M; Genovese, T; Gili, E; Iemmolo, M; Vancheri, C | 1 |
| Conte, E; Cordaro, M; Cuzzocrea, S; Fagone, E; Fruciano, M; Gili, E; Iemmolo, M; Impellizzeri, D; Pistorio, MP; Vancheri, C | 1 |
| Li, Q; Yan, JB; Zhang, LJ | 1 |
| Chen, P; Li, DD; Li, Q; Wu, KF; Yan, JB; Yang, F; Zhang, LJ | 1 |
| Bernstein, KE; Billet, S; Fuchs, S; Gonzalez-Villalobos, RA; Okwan-Duodu, D; Ong, FS; Shen, XZ | 1 |
2 review(s) available for goralatide and Pulmonary Fibrosis
| Article | Year |
|---|---|
[Meta-analysis of Ac-SDKP inhibition of Pulmonary fibrosis in animal models].
Topics: Animals; Disease Models, Animal; Fibrosis; Proline; Pulmonary Fibrosis; Rats; Rats, Wistar | 2023 |
Different in vivo functions of the two catalytic domains of angiotensin-converting enzyme (ACE).
Topics: Animals; Blood Pressure; Catalytic Domain; Fertility; Humans; Oligopeptides; Peptidyl-Dipeptidase A; Pulmonary Fibrosis | 2011 |
10 other study(ies) available for goralatide and Pulmonary Fibrosis
| Article | Year |
|---|---|
Glycolytic Reprogramming in Silica-Induced Lung Macrophages and Silicosis Reversed by Ac-SDKP Treatment.
Topics: Animals; Fibroblasts; Glycolysis; Inflammation; Lung; Macrophages; Macrophages, Alveolar; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Pulmonary Fibrosis; Rats; Rats, Wistar; RNA, Small Interfering; Silicon Dioxide; Silicosis | 2021 |
Synthesis and Identification of a Novel Peptide, Ac-SDK (Biotin) Proline, That Can Elicit Anti-Fibrosis Effects in Rats Suffering from Silicosis.
Topics: A549 Cells; Actins; Animals; Chromatography, High Pressure Liquid; Epithelial-Mesenchymal Transition; Humans; Lung; Male; Oligopeptides; Phagocytosis; Pulmonary Fibrosis; Rats; Rats, Wistar; Silicosis; Transforming Growth Factor beta1 | 2020 |
N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) attenuates silicotic fibrosis by suppressing apoptosis of alveolar type II epithelial cells via mediation of endoplasmic reticulum stress.
Topics: A549 Cells; Administration, Inhalation; Animals; Apoptosis; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Growth Inhibitors; Humans; Male; Oligopeptides; Pulmonary Alveoli; Pulmonary Fibrosis; Rats; Rats, Wistar; Respiratory Mucosa; Silicon Dioxide; Silicosis | 2018 |
Targeting the RAS axis alleviates silicotic fibrosis and Ang II-induced myofibroblast differentiation via inhibition of the hedgehog signaling pathway.
Topics: Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anthracosis; Captopril; Cell Differentiation; Cell Line; Collagen; Disease Models, Animal; Female; Hedgehog Proteins; Humans; Lung; Male; Middle Aged; Myofibroblasts; Oligopeptides; Peptide Fragments; Pulmonary Fibrosis; Rats, Wistar; Renin-Angiotensin System; Signal Transduction; Silicosis | 2019 |
Interaction of N-acetyl-seryl-aspartyl-lysyl-proline with the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis attenuates pulmonary fibrosis in silicotic rats.
Topics: Actins; Angiotensin I; Angiotensin II; Animals; Cell Differentiation; Cells, Cultured; Collagen; Collagen Type I; Fibroblasts; Humans; Male; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Fibrosis; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Silicosis | 2019 |
[Regulating effect of N-acetyl-seryl-aspartyl-lysyl-proline on activation of c-jun N-terminal kinase pathway in rats with silicosis].
Topics: Animals; JNK Mitogen-Activated Protein Kinases; Lung; Male; Oligopeptides; Pulmonary Fibrosis; Rats; Rats, Wistar; Signal Transduction; Silicosis | 2013 |
Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis.
Topics: Animals; Anti-Inflammatory Agents; Bleomycin; Cells, Cultured; Disease Models, Animal; Fibroblasts; Humans; Lung; Male; Mice; Oligopeptides; Pneumonia; Protein Structure, Tertiary; Pulmonary Fibrosis; Thymosin; Transforming Growth Factor beta | 2015 |
Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.
Topics: Actins; Animals; Bleomycin; Chemotaxis, Leukocyte; Collagen; Cytoprotection; Disease Models, Animal; Interleukin-17; Lung; Male; Mice; Myofibroblasts; Oligopeptides; Protective Agents; Pulmonary Edema; Pulmonary Fibrosis; Time Factors; Transforming Growth Factor beta | 2016 |
[Anti-fibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline in lung of rat with silicosis].
Topics: Animals; Collagen; Disease Models, Animal; Drug Antagonism; Lung; Male; Oligopeptides; Pulmonary Fibrosis; Rats; Rats, Wistar; Silicon Dioxide; Silicosis | 2008 |
[Antifibrotic effects of N-acetyl-seryl-aspartyl-lysyl-proline mediated by regulation of transforming growth factor beta and connective tissue growth factor expression on rats with silicosis].
Topics: Animals; Connective Tissue Growth Factor; Disease Models, Animal; Lung; Male; Oligopeptides; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Silicosis; Transforming Growth Factor beta | 2009 |